- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05639842
Pain in Competitive Athletes With Physical Disabilities: Techniques, Support and Perceived Difficulties
December 2, 2022 updated by: Sandra Constantino Murillo, Universidad Politecnica de Madrid
Pain in Competitive Athletes With Physical Disabilities: Techniques for Its Management, Support Received and Perceived Difficulties
Pain in physically disabled athletes affects the sporting career directly or indirectly through psychological consequences.
Numerous studies address psychological skills in able-bodied athletes and in able-bodied athletes they are scarce.This information is part of a research project aimed at finding resources to help athletes in their pain management.
Study Overview
Status
Completed
Conditions
Detailed Description
The purpose of this study is to determine how competitive athletes perceive how pain can affect their sporting careers; what techniques and/or strategies athletes use for pain management and how useful these are; to determine the extent to which athletes with disabilities have received support for pain management and to what extent they have found it useful; and to determine the difficulties they often face in managing their pain.The aim of this questionnaire is to find out how pain, resulting from injury, can affect the sporting careers of competitive athletes with physical disabilities and what techniques they use to manage it.
Study Type
Observational
Enrollment (Actual)
413
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Madrid, Spain, 28410
- Sandra Constantino Murillo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 60 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
A total of 413 participants were interviewed on a voluntary basis.
Spanish and Latin American nationality.
Description
Inclusion Criteria:
Athletes:
- Competitive athletes.
- Physical disability.
- Age without criteria.
Exclusion Criteria:
- Failure to meet the inclusion criteria.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Other
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cross-sectional surveys
Time Frame: 5 months
|
An ad-hoc questionnaire was developed with questions that sought to respond to the specific objectives of this study, taking into consideration the information obtained in the previous qualitative study.
The questionnaire consisted of 74 questions, 68 closed multiple-choice and 6 open-ended, organised into six sections: characteristics of the athlete, how pain affects their sporting career, tolerance and acceptance of pain, techniques and strategies for managing pain, social support for pain management and finally difficulties in pain management.
A Likert scale from 1 (very infrequently) to 5 (very often) was used.Depending on the interpretation of the questions asked in each section, higher scores mean a better or worse result.
|
5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sandra Constantino Murillo, Universidad Politécnica de Madrid.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 9, 2021
Primary Completion (Actual)
December 9, 2021
Study Completion (Actual)
April 17, 2022
Study Registration Dates
First Submitted
November 21, 2022
First Submitted That Met QC Criteria
December 2, 2022
First Posted (Estimate)
December 6, 2022
Study Record Updates
Last Update Posted (Estimate)
December 6, 2022
Last Update Submitted That Met QC Criteria
December 2, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- UPMadrid.
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.